Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of VITROLIFE is 0.8% (low). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
5 mandates
4
active directors
Rickard ERICSSONDirectorLars RisbergDirectorTony Patrick TolfDirector+2 in history
All directors & mandates Publicationslatest 24-03-2026
15
publications in the State Gazette2 directors appointedAll publications & acts Network & structure
2
connected companiesSee network & structure
Connections
2 connected companiesParent · 2 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2017 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.8%
Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate sector
+Young company
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
| Legal nameNL | VITROLIFE |
Registered office
Zwaluwstraat 115A
1840 Londerzeel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.